RxSight, Inc.
RXST
$14.19
$0.886.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.00% | 35.29% | 48.95% | 55.96% | 31.12% |
| Total Depreciation and Amortization | -31.14% | -51.75% | 0.97% | -20.39% | 14.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.79% | 57.55% | 2.47% | 55.73% | 61.23% |
| Change in Net Operating Assets | -33.48% | -11.32% | 418.43% | -216.05% | 39.91% |
| Cash from Operations | 5.12% | 48.68% | 108.14% | 46.63% | 47.60% |
| Capital Expenditure | 70.77% | 46.76% | -68.91% | 16.46% | -163.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.33% | -64.80% | -145.50% | -1,935.35% | 155.11% |
| Cash from Investing | -14.09% | -71.09% | -153.60% | -2,731.29% | 150.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 51.85% | 64.71% | 99.95% | 99.97% | 34.15% |
| Issuance of Common Stock | -93.14% | -16.63% | -72.47% | 396.88% | -84.60% |
| Repurchase of Common Stock | 33.55% | 100.00% | -143.08% | -- | -533.23% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 70.21% | 71.38% | -- |
| Cash from Financing | -109.20% | -16.45% | 110.66% | 12,411.00% | -87.76% |
| Foreign Exchange rate Adjustments | 300.00% | -250.00% | 240.00% | -200.00% | -250.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.80% | 114.46% | -832.23% | -262.99% | 2,892.46% |